Form for updating ma nonprofit
“Chris’ background spans a broad spectrum of legal areas.She has extensive experience working with both private and public emerging biotech companies,” said Steven Tregay, Ph. “Chris brings to FORMA essential and in-depth experience which will be invaluable for meeting our strategic company objectives and, most importantly, ensuring that FORMA is successful in delivering on our promise of creating innovative medicines for patients who need them most.” “I am thrilled to be joining FORMA at this stage of its growth and development,” said Chris Bellon.
The continuation of our productive collaboration is a tribute to our team of talented scientists and clinicians who have and continue to bring forth potentially important new medicines for people with cancer and other serious diseases.” FORMA Therapeutics’ scientists are passionate about discovering and developing medicines that will make a difference in oncology, inflammation & immunity, and other serious diseases.Before joining Relay Therapeutics, Chris spent 5 years with Blueprint Medicines serving as their VP of Legal Affairs.She also previously served at Hydra Biosciences and Infinity Pharmaceuticals in varying legal and intellectual property leadership positions.“FORMA’s drug discovery engine and network of collaborators have already demonstrated the capability to produce a broad and robust pipeline, and I am eager to contribute to this effort.” Chris holds a juris doctor degree from Columbia Law School of New York and a Ph. in Organic Chemistry from Massachusetts Institute of Technology after graduating with a bachelor’s degree in Chemistry from Yale University.About FORMA FORMA Therapeutics’ scientists are passionate about discovering and developing medicines that will make a difference in oncology and other genetically driven therapeutic areas.
are pleased to see tractable progress of protein-protein modulators and to have contributed to BI’s clinical candidate pipeline, enabled by the collective grit of R&D teams, boldly and courageously taking on such challenging programs.” WATERTOWN, Mass.